FSTL5Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma

Title
FSTL5Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 29, Issue 29, Pages 3852-3861
Publisher
American Society of Clinical Oncology (ASCO)
Online
2011-09-13
DOI
10.1200/jco.2011.36.2798

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started